Skip to main content

Table 1 Baseline characteristics of 27 patients with BCLM

From: Clinical application of gelatin sponge microparticles combined with pirarubicin for hepatic transcatheter arterial chemoembolization in breast cancer liver metastasis treatment: results of a single-center long-term study

Clinical features

Value

Average age (years) (range)

55.17 ± 9.06 (33–79)

 60 years

21

  ≥ 60 years

6

Menstrual state

 Premenopausal

9

 Postmenopausal

18

Pathological subtype

 Invasive ductal carcinoma

26

 Invasive lobular carcinoma

1

Primary tumor size (cm)

 2

15

 2–5

6

  ≥ 5

5

 Invasion of chest wall skin

1

Axillary metastatic lymph nodes (number)

 0

14

 1–34

8

  ≥ 4

5

ER/PR

  + 

18

  − 

9

Her-2

  + 

15

  − 

12

Time to postoperative liver metastasis (months)

  < 24

16

  ≥ 24

11

Intrahepatic lesions (number)

 Single

5

 Multiple

22

Intrahepatic lesion size (cm)

 3

3

 ≥ 3

24

Whether combination therapy was adopted

 Yes

18

 No

9

Whether complicated by extrahepatic metastasis

 Yes

16

 No

11

 Number of interventional treatment sessions (range)

2.44 ± 1.58 (1–6)

  1. ER/PR estrogen receptor/progesterone receptor